Hospital for Joint Diseases - Lupus
Edit Page
Report
Scan day: 13 February 2014 UTC
42
Virus safety - good
Description: By H Michael Belmont, MD, Rheumatologist, specialist in the treatment, research, and the care of affected patients. Also book sales.
Systemic Lupus Erythematosus (SLE) Clinical Overview Medical Director, Hospital for Joint Diseases New York University Medical Center Systemic Lupus Erythematosus (SLE) is a chronic, usually life-long, potentially fatal autoimmune disease characterized by unpredictable exacerbations and remissions with variable clinical manifestations. In Lupus SLE there is a high probability for clinical involvement of the joints, skin, kidney, brain, lung, heart, serosa and gastrointestinal tract. Women and minorities are disproportionately affected and Lupus SLE is most common in women of child-bearing age although it has ben reported in both extremes of life (e.g. diagnosed in infants and in the tenth decade of life). The prevalence in the Unites States had been estimated as approximately 500,000 but a recent telephone survey commissioned by the Lupus Foundation of America suggested a prevalence of as many as 2,000,000. A recent study identified a prevalence of 500 per 100,000 (1:200) in women residing in the area surrounding Birmingham, Alabama.
Size: 1049 chars
Contact Information
Email:Send Message
Phone&Fax: —
Address: —
Extended: —
WEBSITE Info
| Page title: | Systemic Lupus Erythematosus (SLE) Clinical Overview |
| Keywords: | lupus, SLE, diagnosis, symptoms, Systemic Lupus Erythematosus, review, disease, clinical overview, belmont |
| Description: | Clinical overview of Systemic Lupus Erythematosus (SLE), a chronic, usually life-long, potentially fatal autoimmune disease. |
| IP-address: | 74.55.89.131 |
WHOIS Info
| NS | Name Server: NS1.CEREBEL.COM Name Server: NS2.CEREBEL.COM |
| WHOIS | Status: clientTransferProhibited |
| Date | Creation Date: 05-dec-1995 Expiration Date: 04-dec-2016 |